Norwegian vitamin K2 company NattoPharma ASA in talks regarding global sales and distribution agreement

7 Stocks You Need To Know For Tomorrow -- Free Newsletter

May 09, 2008 (NORDIC BUSINESS REPORT via COMTEX) -- -- Norwegian natural vitamin K2 products developer NattoPharma ASA issued a brief announcement on Friday (9 May), saying that it is in talks regarding a global sales and distribution agreement with a leading international player in the nutrition and pharmaceutical market.

NattoPharma said that it expects to sign a letter of intent "in the near future".

No additional information has yet been disclosed.

NattoPharma, headquartered in Oslo, Norway, sells and develops the natural vitamin K2 product MenaQ7. The company expects to achieve a turnover of NOK80-90m in 2008.

One British pound (GBP) is worth approximately 10.17 Norwegian kroner (NOK).

Comments on this story may be sent to nbr.feedback@nordicbusinessreport.com

Morning Coffee with TradingMarkets -- Free Newsletter

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index